Search

Search Results

• A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

  Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  06-06-2023

  https://doi.org/10.4081/dr.2023.9722

  854

  PDF: 488

  HTML: 27
• 

  Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

  Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske

  e57

  13-12-2011

  https://doi.org/10.4081/dr.2011.e57

  1964

  PDF: 747

  HTML: 1027

• Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

  Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani

  04-02-2025

  https://doi.org/10.4081/dr.2025.10232

  572

  PDF: 364

  HTML: 27

• Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

  Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris

  03-02-2026

  https://doi.org/10.4081/dr.2026.10644

  766

  PDF: 510

• The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

  Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi

  01-07-2025

  https://doi.org/10.4081/dr.2025.10112

  1028

  PDF: 768

  HTML: 40

• Scabies mimicking relapsing atopic dermatitis

  Flavia Pigliacelli, Elva Abril, Norma Cameli, Paolo Iacovelli, Maria Mariano

  09-08-2024

  https://doi.org/10.4081/dr.2024.10070

  1109

  PDF: 707

  HTML: 110

• 67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni¹, L. Eichenfield², J. Ornelas³, V. Prajapati⁴, C. Yang⁵, A. Tanaka⁶, S. Weidinger⁷, C. Flohr⁸, E. Swanson⁹, L. Martin¹⁰, S. Daveiga¹¹, R. Gontijo Lima¹¹, H. Elmaraghy¹¹, E. Pierce¹¹, P. Sen¹¹, G. Gallo¹¹, M. Piruzeli¹¹, A. Larkin¹¹, M. Grau¹², Y. Mihaylov¹², A. Paller¹³ | ¹Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; ²Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; ³Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; ⁴Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; ⁵Chang Gung University College of Medicine, Taoyuan, Taiwan; ⁶Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; ⁷Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; ⁸Department of Dermatology and Population Health Sciences, King’s College London, UK; ⁹Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; ¹⁰School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; ¹¹Eli Lilly and Company, Indianapolis, Indiana, USA; ¹²Almirall R&D, S.A., Barcelona, Spain; ¹³Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11114

  99

  PDF: 44

• Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

  Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi

  21-02-2025

  https://doi.org/10.4081/dr.2025.10278

  506

  PDF: 327

  HTML: 25

• Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

  Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

  01-07-2025

  https://doi.org/10.4081/dr.2025.10315

  633

  PDF: 326

  HTML: 25
• 

  Herpes vegetans, an atypical herpes lesion in HIV patient: A case report

  Sondang P. Sirait, Wresti Indriatmi

  14-03-2022

  https://doi.org/10.4081/dr.2022.9180

  2755

  PDF: 904

  HTML: 25

• CD4/CD8 double-negative mycosis fungoides: a review

  Khalid Nabil Nagshabandi, Abdulrahman Shadid, Asem Shadid, Nouf K. Almuhanna

  12-04-2024

  https://doi.org/10.4081/dr.2024.9908

  3331

  PDF: 659

  SUPPLEMENTARY: 133

  HTML: 37

• 31 | DRUG ECONOMIC ANALYSIS OF THE DOSE SPACING OF BIOLOGICAL DRUGS IN ATOPIC DERMATITIS AND PSORIASIS A. Filoni¹, L. Pietroleonardo¹, P. Stasi², M. Spagnolo², F. Scicchitano², S. Pelle³, M. Congedo¹ | ¹UOSVD Dermatology and Allergology, Hospital Vito Fazzi, Lecce, Italy; ²Servizio Farmaceutico Distrettuale. Asl Lecce, Italy; ³Dermatology Outpatient Unit, Asl Lecce, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11064

  85

  PDF: 32

• Mendelian randomization analysis of the causal relationship between immune cells and keloid

  Jingwen Zou, Pengkhun Nov, Kunpeng Du

  23-10-2024

  https://doi.org/10.4081/dr.2024.10106

  883

  PDF: 463

  SUPPLEMENTARY MATERIAL: 164

  HTML: 23
• 

  Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

  Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

  01-10-2018

  https://doi.org/10.4081/dr.2018.7859

  2130

  PDF: 1099

  HTML: 88
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  https://doi.org/10.4081/dr.2023.9630

  1121

  PDF: 592

  HTML: 96

• Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

  Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

  13-03-2025

  https://doi.org/10.4081/dr.2025.10021

  537

  PDF: 362

  HTML: 15
• 

  Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

  Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

  28-12-2021

  https://doi.org/10.4081/dr.2022.9454

  4154

  PDF: 693

  APPENDIX: 198

  HTML: 20

• 23 | CURRENT CHALLENGES IN MODERATE ATOPIC DERMATITIS: AN ITALIAN DELPHI CONSENSUS I. Marzona¹, A. Costanzo², A. Campanati³, M. Esposito⁴, S. M. Ferrucci⁵, G. Girolomoni⁶, C. Patruno⁷, E. Pezzolo⁸, S. Ribero⁹, M. Rossi¹⁰, L. Stingeni¹¹, L. Politi¹, M. Napolitano¹² | ¹Helaglobe Srl; ²Dermatology Unit, IRCCS Humanitas Research Hospital Dermatology, Italy; ³Dermatological Clinic, Università Politecnica delle Marche, Italy; ⁴Biotechnological and Clinical Sciences University of L’Aquila, Italy; ⁵IRCCS Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Italy; ⁶Section of Dermatology, University of Verona, Italy; ⁷Medicine and Health Sciences, Molise University, Italy; ⁸Department of Dermatology, San Bortolo Hospital, Italy; ⁹Dermatology Clinic, University of Turin, Italy; ¹⁰Dermatology Unit, University of Brescia, Italy; ¹¹Dermatology Section, University of Perugia, Italy; ¹²Section of Dermatology, University of Naples, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11085

  92

  PDF: 111

• Paradoxical reaction under dupilumab triggered by occasional ketoprofen intake

  Filippo Chersi, Sanja Javor, Rosella Gallo, Elia Sala, Cesare Massone

  28-02-2025

  https://doi.org/10.4081/dr.2025.10214

  1001

  PDF: 762

  HTML: 15

• The efficacy of apremilast in pemphigus: a systematic review of case reports

  Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri

  07-05-2025

  https://doi.org/10.4081/dr.2025.10245

  1053

  PDF: 465

  SUPPLEMENTARY MATERIAL: 70

  HTML: 20

• A microRNA focus on acne

  Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

  02-02-2024

  https://doi.org/10.4081/dr.2024.9902

  1161

  PDF: 751

  HTML: 73
• 

  Narrowband UVB-induced lichen planus pemphigoides

  Wai Man Mandy Chan, Joyce Siong See Lee, Colin Seng Thiam Theng, Sze Hon Chua, Hazel Hwee Boon Oon

  e43

  25-10-2011

  https://doi.org/10.4081/dr.2011.e43

  2794

  PDF: 854

  HTML: 1353
• 

  Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

  Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

  29-12-2022

  https://doi.org/10.4081/dr.2023.9613

  1829

  PDF: 565

  HTML: 102

• Does the response to bimekizumab vary according to previous therapy with methotrexate versus cyclosporine?

  Ilaria Salvi, Alexandra M. G. Brunasso, Franco Castelli, Andrea Michelerio, Paolo Pella, Marco Rubatto, Paolo Dapavo, Emanuele Cozzani, Martina Burlando

  20-03-2026

  https://doi.org/10.4081/dr.2026.10236

  353

  PDF: 300

• Acute generalized exanthematous pustulosis triggered by dupilumab

  Caterina Mariarosaria Giorgio, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Anna Balato, Eugenia Veronica Di Brizzi

  23-07-2025

  https://doi.org/10.4081/dr.2025.10219

  546

  PDF: 357

  HTML: 28